Results 361 to 370 of about 5,474,833 (393)
KIF3C inhibits the progression and proliferation of colorectal cancer. [PDF]
BMC GastroenterolDiallo MT +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Surgical Oncology, 2022
AbstractAlthough surgery is the established standard and mainstay for treatment of colorectal cancer, advances in technology and clinical trials over the past 50 years have dramatically expanded and improved the detection, staging, treatment, and understanding of this disease.
Philip B. Paty, Julio Garcia‐Aguilar
semanticscholar +7 more sources
AbstractAlthough surgery is the established standard and mainstay for treatment of colorectal cancer, advances in technology and clinical trials over the past 50 years have dramatically expanded and improved the detection, staging, treatment, and understanding of this disease.
Philip B. Paty, Julio Garcia‐Aguilar
semanticscholar +7 more sources
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review.
Journal of the American Medical Association (JAMA), 2021Importance Colorectal cancer (CRC) is the third most common cause of cancer mortality worldwide with more than 1.85 million cases and 850 000 deaths annually. Of new colorectal cancer diagnoses, 20% of patients have metastatic disease at presentation and
Leah H. Biller, D. Schrag
semanticscholar +1 more source
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
Journal of the American Medical Association (JAMA), 2021Importance Colorectal cancer is the third leading cause of cancer death for both men and women, with an estimated 52 980 persons in the US projected to die of colorectal cancer in 2021. Colorectal cancer is most frequently diagnosed among persons aged 65
K. Davidson +17 more
semanticscholar +1 more source
Clinical Oncology, 2016
Globally, cervical cancer is the second most common type of cancer and the second leading cause of cancer death among women. The incidence varies geographically because of differences in the availability of screening programs and access to them. For example, in Africa, cervical cancer is the leading cause of cancer deaths among women, but in the United
D C, Gilbert, S J, Falk
+7 more sources
Globally, cervical cancer is the second most common type of cancer and the second leading cause of cancer death among women. The incidence varies geographically because of differences in the availability of screening programs and access to them. For example, in Africa, cervical cancer is the leading cause of cancer deaths among women, but in the United
D C, Gilbert, S J, Falk
+7 more sources